Ake­so rais­es $250M; Sali­o­Gen’s lay­offs

Plus, news about Nicox, Soleus and Mol­e­c­u­lar Tem­plates:

Ake­so Bio­phar­ma’s $250M place­ment: The Hong Kong-based com­pa­ny, which is de­vel­op­ing a close­ly watched bis­pe­cif­ic an­ti­body with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER